|Videos|July 23, 2013
Episode 6 - Addressing the Gaps in Care for Hemophilia Patients
Advertisement
Delivering the optimal care to patients with hemophilia is often a challenge, both clinically and financially. According to Patrick Fogarty, MD, the individuals who are best fit to execute treatment guidelines are those who practice at specialty hemophilia treatment centers, as they are able to provide on-site multidisciplinary, comprehensive care.
However, the panelists conclude that there are still gaps in current treatment guidelines that require addressing. In an effort to provide the best of care to all patients with hemophilia, regardless of geography, strategies such as home care, satellite clinics, and increased patient education have been implemented into contemporary treatment paradigms.
Advertisement
Related to this article
Amanda Velazquez, MD, discusses GLP-1 formulary strategies, overcoming prior authorization hurdles, and building scalable obesity care infrastructure.
Cepheid's Connie Savor, MD, MBA, explains where its 13-pathogen respiratory panel fits in diagnostic stewardship and antibiotic decisions.
A legal fight over a single amino acid could set retatrutide's exclusivity window, its Medicare negotiation clock, and its competitive future.
Medicaid expansion was associated with lower colorectal cancer mortality, with the largest reductions in Hispanic patients and stage IV disease.
Older adults on Medicare report the best access to care among 10 countries but more cost-related problems and higher out-of-pocket spending.
Even when physicians prescribe guideline-preferred therapies, step therapy and prior authorization can delay or restrict access to CLL therapies.
Michael Mina, MD, PhD, explains Invivyd's accelerated approval path for VYD2311 and how it could change the timing of COVID-19 protection.
The study authors note there is an urgent need for "innovative value-based and alternative payment models of care."
Advertisement
Advertisement
Trending on AJMC
1
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
2
NEI Director Highlights Pediatric Advances, AI’s Promise in Eye Care
3
GLP-1s Have Protective Benefit Against DME, Glaucoma Surgery
4
Keynote Address Tackles AI’s Role in Health Care, Eye Care
5